Last Wednesday (September 25), the Australian Capital Territory (ACT) passed legislation to legalize the use and cultivation of cannabis, becoming the first region in Australia to do so.

Under the new legislation, which is set to come into effect in January, individuals over 18 will be able to possess up to 50 grams of dried flower and cultivate two marijuana plants at home with a maximum of four plants per residence.


The new legislation hasn’t completely opened the doors in Australia, however, as the sale of cannabis plants and seeds and smoking cannabis publicly is still illegal at the federal level.

Australia has been developing a medical cannabis sector since 2016, but the new legislation is at odds with overarching Commonwealth law, meaning people could still technically be charged for cultivation and possession.

Alexandra Curley, head of insights at Prohibition Partners, told the Investing News Network (INN) in an email that there are still questions surrounding the new rules when it comes to developing a cannabis sector in the country.

“It is unlikely to create a market for cannabis (at least in the near future),” Curley told INN. “(Prohibition Partners) would regard this as more of a social landmark than an economic one.”

Curley added that the move may have been an attempt to control the black market for cannabis.

In a previous interview, Curley confirmed that there is growing interest from investors overseas and in the country for the Australian marijuana opportunity.

ACT Labor member Michael Pettersson, the man behind the bill, said there is a defense available for cannabis use against Commonwealth law if it comes up against state law.

“Commonwealth law has been written with the express understanding that there are differences,” he said. “I don’t think it’s particularly likely the Commonwealth government will try to fight this.”

The legislation could benefit the 100,000 people using homegrown cannabis to treat their medical issues, Curley told INN.

“In this way, legislation will certainly have benefits, especially for those who know what they need and who have struggled to afford or access a legal prescription,” she said.

But for companies, this isn’t likely to affect market value, she continued. It could, however, push the country to loosen its existing cannabis laws in a “domino effect,” especially if the new legalization doesn’t lead to any increases in public health issues.

She also said a “gray market” could arise, like the one in Washington, DC, where customers can buy legal items, such as clothing or food, from stores and receive a free gift of dried flower with their purchase.

She cautioned that Section 122 of the Australian Constitution allows federal parliament to override territory laws.

Despite the legal tension, the new legislation is still an important step for cannabis legalization in Australia, helping to normalize the use of the drug. It’s something Curley said could provide a blueprint for the emerging industry.

She said the legalization of personal cultivation is “particularly powerful” as it suggests the country isn’t solely focused on building revenue.

“Australia has been making some pretty loud noises about securing its place in the global cannabis market as a supply behemoth — and this development reveals that it isn’t just about the financials.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the closing of its previously announced overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for total gross proceeds of approximately US$125 million.

The Offered Securities were offered in each of the Provinces of Canada, other than Québec, pursuant to a prospectus supplement dated January 19, 2021 to the Company’s base shelf prospectus dated July 25, 2019 (collectively, the “Prospectus”) and in the United States on a private placement basis to “qualified institutional buyers” pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended (the ” U.S. Securities Act “).

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (FWB:8OO) (“ HempFusion ” or the “ Company ”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, will celebrate the Company’s listing on the Toronto Stock Exchange (“TSX”) by virtually ringing the TSX opening bell at 9:30 a.m. ET today. As previously announced, HempFusion completed its $17,000,000 initial public offering and commenced trading on the TSX on January 6, 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210122005074/en/

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

 Numinus Wellness Inc. (” Numinus ” or the ” Company “) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, is pleased to announce that the TSX Venture Exchange (” TSXV “) has accepted for listing the 12,683,925 warrants (the ” Warrants “) issued pursuant to the Company’s previously announced prospectus offering that closed on December 29, 2020 .

Keep reading... Show less